Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis. [electronic resource]
Producer: 20040203Description: 2123-6 p. digitalISSN:- 0315-162X
- Adult
- Aged
- Antibodies -- blood
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Immunoglobulin Heavy Chains
- Immunoglobulin gamma-Chains
- Infusions, Intravenous
- Joints -- drug effects
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.